ACEA Biosciences, Inc. Company Profile

02:45 EDT 19th June 2019 | BioPortfolio

Founded in 2002, ACEA Biosciences is a pioneer in the development and commercialization of high performance, cutting edge cell analysis platforms for life science research. ACEA’s xCELLigence® impedance-based, label-free, real-time cell analysis instruments and NovoCyte® flow cytometer are used in pre-clinical drug discovery and development, toxicology, safety pharmacology, and basic academic research. More than 2,000 instruments have been placed globally.

News Articles [641 Associated News Articles listed on BioPortfolio]

Agilent Closes $250 Million Acquisition of ACEA, a US-China Lab Tools Maker

Agilent Technologies closed its $250 million acquisition of ACEA Biosciences, a San Diego-Hangzhou company that provides cell analysis tools. ACEA is focused on real-time, live cell analysis of cell f...

ACEA Biosciences Joins Cell Manufacturing Research Initiative to Further Advance Cell Therapy Discovery

Research Collaboration Aims to Revolutionize Treatment of Cancer through Efficient Production of High-Quality Immune Cell Therapies SAN DIEGO, Calif. (PRWEB) November 29, 2018 ACEA Biosciences, now a...

ACEA Biosciences and PhysioStim Announce Partnership to Provide Comprehensive In Vitro Cardiac Safety Assessment Services

ACEA Biosciences and PhysioStim will work together to provide comprehensive in vitro cardiac safety and toxicity assessment services in Europe SAN DIEGO (PRWEB) March 07, 2019 ACEA Biosciences Inc. (...

Personalized Medicine: A New Approach to Treat Periodontal Diseases

New clinical research uses xCELLigence Real-Time Cell Analysis to determine the optimal antibiotic for treating gum disease SAN DIEGO (PRWEB) March 18, 2019 Periodontal disease, where bacterial infec...

ACEA Biosciences – A Part of Agilent Launches the xCELLigence RTCA ePacer to improve the Quality and Functionality of hiPSC-Cardiomyocytes for Drug Discovery, Safety Pharmacology, and Cardiac Disease Research

The new xCELLigence RTCA ePacer provides a solution that uses electrical pacing to functionally mature cardiomyocytes. On March 11, 2019, ACEA Biosciences – A Part of Agilen...

AUM Biosciences looks to advance anti-cancer molecule to Phase 2 later this year

AUM Biosciences CEO Vishal Doshi sat down with Proactive Investors at the BIO CEO and Investor Conference in New York. AUM Biosciences is a Singapore-based oncology-focused biotech company.

ACEA Presents xCELLigence Research Grant to Dr. Teresa Krabbe

German scientist will employ xCELLigence Real Time Cell Analysis (RTCA) technology to develop an oncolytic virus and use T cell receptor (TCR) transgenic T cells to deliver the virus to specific tumor...

Agilent Completes Acquisition of ACEA Biosciences

Acquisition Brings Together Two Pioneers in Cellular Function and Metabolism Measurements Agilent Technologies Inc. (NYSE: A) today announced it has completed the ...

Drugs and Medications [33 Associated Drugs and Medications listed on BioPortfolio]

Eptifibatide [amneal biosciences]

These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION . EPTIFIBATIDE injection,...

Natelle one [meda pharmaceuticals]


Isoproterenol hydrochloride [amneal biosciences llc]

Isoproterenol Hydrochloride Injection, USP Rx only Sterile Injection

Spherusol [nielsen biosciences, inc.]

These highlights do not include all the information needed to use Spherusol safely and effectively. See full prescribing information for Spherusol . Coccidioides immitis Spherule-Derived Skin Test Ant...

Natelle one [azur pharma, inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

PubMed Articles [74 Associated PubMed Articles listed on BioPortfolio]

Levetiracetam combined with ACEA, highly selective cannabinoid CB1 receptor agonist changes neurogenesis in mouse brain.

The aim of the study was to evaluate the impact of second generation antiepileptic drug levetiracetam (LEV) with arachidonyl-2'-chloroethylamide (ACEA) on proliferating neural precursor cells in mouse...

New Zealand nursing students' perceptions of biosciences: A cross-sectional survey of relevance to practice, teaching delivery, self-competence and challenges.

Bioscience subjects are one of the most discussed nursing curricula contents in terms of the longed known teaching and learning challenges for nursing students. Recent studies examined the specific us...


(Chemo-) enzymatic cascade reactions.

Fragile X Mental Retardation Protein: To Be or Not to Be a Translational Enhancer.

Clinical Trials [11 Associated Clinical Trials listed on BioPortfolio]

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Rheumatoid Arthritis

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment fo...

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

A Registry of Patients With Primary Choroidal Melanoma (CM) or Indeterminate Lesions (ILs)

The purpose of this observational research study is to follow participants who have been treated with either AU-011 or observation and/or received standard of care therapy while participat...

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Companies [387 Associated Companies listed on BioPortfolio]

ACEA Biosciences, Inc.

Founded in 2002, ACEA Biosciences is a pioneer in the development and commercialization of high performance, cutting edge cell analysis platforms for life science research. ACEAâ...

ACEA Biosciences

ACEA Biosciences, founded in 2002, is a privately held biotechnology company located in San Diego, California. ACEA is developing a broad biosensor platform based on proprietary microelectronic techno...

ACEA Biosciences, a part of Agilent Technologies

ACEA Biosciences, a part of Agilent Technologies, is a pioneer in the development and commercialization of high-performance cell analysis platforms for life science research. ACEA...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

More Information about "ACEA Biosciences, Inc." on BioPortfolio

We have published hundreds of ACEA Biosciences, Inc. news stories on BioPortfolio along with dozens of ACEA Biosciences, Inc. Clinical Trials and PubMed Articles about ACEA Biosciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ACEA Biosciences, Inc. Companies in our database. You can also find out about relevant ACEA Biosciences, Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record